Very early in her career working in the over-the-counter (OTC) sector, Michelle Riddalls, saw the benefit of reclassifying medicine can have on patient access to medicine and self-care.
“I started in OTC back in 2001 in the regulatory field and one of the first products I was looking after was Calpol,” Riddalls told Pharmacy Business.
“What I enjoyed about it way back then, and it's still true now, is that you saw the changes that you were helping make in consumer health and widening access to medicines and making a difference to people's lives straight away.”
read more..